Abilify and Syncope aggravated - a phase IV clinical study of FDA data
Summary:
Syncope aggravated is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Seroquel, and have Schizophrenia.
The phase IV clinical study analyzes which people have Syncope aggravated when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,453 Abilify users. Check the latest studies of Abilify.
What is Syncope aggravated?
Syncope aggravated (a loss of consciousness with an inability to maintain postural tone) is found to be associated with 1,681 drugs and 588 conditions by eHealthMe. Check the latest studies of Syncope aggravated.
97,308 people reported to have side effects when taking Abilify.
Among them, 650 people (0.67%) have Syncope aggravated.

Among these 650 people:
How long have people been on Abilify when they have Syncope aggravated? *
What is the gender of people who have Syncope aggravated when taking Abilify? *
What is the age of people who have Syncope aggravated when taking Abilify? *
What are other drugs people take besides Abilify? *
What are other side effects people have besides Syncope aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Syncope aggravated?
- Check whether Syncope aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,453 reports)
Syncope aggravated treatments and more:
- Syncope aggravated (17 reports)
How severe was Syncope aggravated and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Syncope aggravated:
- Syncope aggravated (1,681 drugs)
Browse all the conditions that are associated with Syncope aggravated:
- Syncope aggravated (588 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Erelzi cause Musculoskeletal Discomfort? - 7 seconds ago
- Tecfidera vs. Vitamin D, side effect and effectiveness comparison - 11 seconds ago
- Could Vabysmo cause Dizziness Aggravated? - 14 seconds ago
- Could Prednisone cause Injection Site Dermatitis? - 17 seconds ago
- Could Apokyn cause Nightmares? - 18 seconds ago
- Could Epiduo cause Dry Eyes? - 18 seconds ago
- Could Fenoterol Hydrobromide cause Abdominal Distension? - 26 seconds ago
- Chronic Thyroiditis and drugs of ingredients of rosuvastatin calcium - 28 seconds ago
- Folic Acid and Eye Swelling for Men aged 50-59 - 30 seconds ago
- Could Cozaar cause Nosebleed? - 38 seconds ago